ArticleMolecular and clinical oncology2022

Role of the EGFR-KDD mutation as a possible mechanism of acquired resistance of non-small cell lung cancer to EGFR tyrosine kinase inhibitors: A case report.

Cheng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.